Applied dna initiates analytical validation of pcr-based diagnostic test specific to monkeypox virus

Stony brook, n.y.--(business wire)---- $apdn #ldt--applied dna sciences, inc. (nasdaq: apdn) (the “company”), a leader in polymerase chain reaction (“pcr”)-based technologies, announced that its wholly-owned clinical laboratory subsidiary, applied dna clinical labs, llc (“adcl”), has initiated analytical validation of a company-developed, pcr-based monkeypox virus test that is specific for the genetic signature of the monkeypox virus. the test has been developed as a type of nysdoh laboratory developed test (
APDN Ratings Summary
APDN Quant Ranking